VYNE Therapeutics
VYNE
#9889
Rank
ยฃ18.39 M
Marketcap
ยฃ1.21
Share price
-6.59%
Change (1 day)
-45.98%
Change (1 year)

VYNE Therapeutics (VYNE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : ยฃ11.49 Million

According to VYNE Therapeutics's latest financial reports the company's total liabilities are ยฃ11.49 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

VYNE Therapeutics - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ11.8 M68.09%
2023-12-31ยฃ7.02 M-11.06%
2022-12-31ยฃ7.89 M-42.09%
2021-12-31ยฃ13.63 M-66.95%
2020-12-31ยฃ41.26 M407.58%
2019-12-31ยฃ8.13 M8.05%
2018-12-31ยฃ7.52 M-91.79%
2017-12-31ยฃ91.67 M58.22%
2016-12-31ยฃ57.94 M43.49%
2015-12-31ยฃ40.37 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ24.05 M 109.33%๐Ÿ‡บ๐Ÿ‡ธ USA